1,513
Views
19
CrossRef citations to date
0
Altmetric
Comprehensive Review

Discovery of nutritional biomarkers: future directions based on omics technologies

&
Pages S31-S40 | Received 05 Dec 2014, Accepted 25 Mar 2015, Published online: 01 Aug 2015

References

  • Aggett PJ, Antoine JM, Asp NG, Bellisle F, Contor L, Cummings JH, Howlett J, et al. 2005. PASSCLAIM: consensus on criteria. Eur J Nutr 44:i5–i30
  • Ali S, Chopra R, Manvati S, Singh YP, Kaul N, Behura A, Mahajan A, et al. 2013. Replication of type 2 diabetes candidate genes variations in three geographically unrelated Indian population groups. PLoS One 8:e58881
  • Almeida R, Allshire RC. 2005. RNA silencing and genome regulation. Trends Cell Biol 15:251–258
  • Allen LH, Wood RJ. 1994. Calcium and phosphorus. In: Shils ME, Olson JA, Shike M, editors. Modern nutrition in health and disease. Philadelphia: Lea & Febiger. p 144–163
  • Baker ES, Liu T, Petyuk VA, Burnum-Johnson KE, Ibrahim YM, Anderson GA, Smith RD. 2012. Mass spectrometry for translational proteomics: progress and clinical implications. Genome Med 4:63–74
  • Baker M. 2005. In biomarkers we trust? Nat Biotechnol 23:297–304
  • Batch BC, Shah SH, Newgard CB, Turer CB, Haynes C, Bain JR, Muehlbauer M, et al. 2013. Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. Metabolism 62:961–969
  • Bendik I, Friedel A, Roos FF, Weber P, Eggersdorfer M. 2014. Vitamin D: a critical and essential micronutrient for human health. Front Physiol 5:248–262
  • Biomarkers Definitions Working Group. 2001. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95
  • Bodzon-Kulakowska A, Bierczynska-Krzysik A, Dylag T, Drabik A, Suder P, Noga M, Jarzebinska J, Silberring J. 2007. Methods for samples preparation in proteomic research. J Chromatogr B Anal Technol Biomed Life Sci 849:1–31
  • Borel P, Grolier P, Mekki N, Boirie Y, Rochette Y, Le Roy B, Alexandre-Gouabau MC, et al. 1998. Low and high responders to pharmacological doses of beta-carotene: proportion in the population, mechanisms involved and consequences on beta-carotene metabolism. J Lipid Res 39:2250–2260
  • Brennan L. 2013. Metabolomics in nutrition research: current status and perspectives. Biochem Soc Trans 41:670–673
  • Buermans HP, den Dunnen JT. 2014. Next generation sequencing technology: advances and applications. Biochim Biophys Acta 1842:1932–1941
  • Caruso MG, Gazzerro P, Notarnicola M, Cisternino AM, Guerra V, Misciagna G, Laezza C, Bifulco M. 2012. Cannabinoid type 1 receptor gene polymorphism and macronutrient intake. J Nutrigenet Nutrigenomics 5:305–313
  • Casal JI, Barderas R. 2010. Identification of cancer autoantigens in serum: toward diagnostic/prognostictesting? Mol Diagn Ther 14:149–154
  • Cervi D, Pak B, Venier NA, Sugar LM, Nam RK, Fleshner NE, Klotz LH, Venkateswaran V. 2010. Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4. BMC Cancer 10:258
  • Claus SP, Swann JR. 2013. Nutrimetabonomics: applications for nutritional sciences, with specific reference to gut microbial interactions. Annu Rev Food Sci Technol 4:381–399
  • Combs GF Jr, Trumbo PR, McKinley MC, Milner J, Studenski S, Kimura T, Watkins SM, Raiten DJ. 2013. Biomarkers in nutrition: new frontiers in research and application. Ann NY Acad Sci 1278:1–10
  • Cross AJ, Major JM, Sinha R. 2011. Urinary biomarkers of meat consumption. Cancer Epidemiol Biomarkers Prev 20:1107–1111
  • Cunsolo V, Muccilli V, Saletti R, Foti S. 2014. Mass spectrometry in food proteomics: a tutorial. J Mass Spectrom 49:768–784
  • Delgado-Lista J, Perez-Martinez P, Solivera J, Garcia-Rios A, Perez-Caballero AI, Lovegrove JA, Drevon CA, et al. 2014. Top single nucleotide polymorphisms affecting carbohydrate metabolism in metabolic syndrome: from the LIPGENE study. J Clin Endocrinol Metab 99:E384–E389
  • Diamandis EP. 2014. Present and future of cancerbiomarkers. Clin Chem Lab Med 52:791–794
  • Dondeti VR, Sipe CW, Saha MS. 2004. In silico gene selection strategy for custom microarray design. Bio Techniques 37:768–70, 772, 774–776
  • Edmands WM, Beckonert OP, Stella C, Campbell A, Lake BG, Lindon JC, Holmes E, Gooderham NJ. 2011. Identification of human urinary biomarkers of cruciferous vegetable consumption by metabonomic profiling. J Proteome Res 10:4513–4521
  • EFSA Scientific Committee. 2010. Guidance on human health risk-benefit assessment of foods. EFSA J 8:1673–1713
  • EFSA Scientific Report. 2014. Modern methodologies and tools for human hazard assessment of chemicals. EFSA J 12:36–38
  • Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS. 2003. Tea polyphenol (−)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63:7563–7570
  • Fang X, Zhang WW. 2008. Affinity separation and enrichment methods in proteomic analysis. J Proteomics 71:284–303
  • Fenech M. 2005. The genome health clinic and genome health nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Mutagenesis 20:255–269
  • Fey SJ, Larsen PM. 2001. 2D or not 2D. Two-dimensional gel electrophoresis. Curr Opin Chem Biol 5:26–33
  • Fogle RL, Lynch CJ, Palopoli M, Deiter G, Stanley BA, Vary TC. 2010. Impact of chronic alcohol ingestion on cardiac muscle protein expression. Alcohol ClinExp Res 34:1226–1234
  • Frishman WH. 1998. Biologic markers as predictors of cardiovascular disease. Am J Med 104:18S–27S
  • Frozza CO, RibeiroTda S, Gambato G, Menti C, Moura S, Pinto PM, Staats CC, et al. 2014. Proteomic analysis identifies differentially expressed proteins after red propolis treatment in Hep-2 cells. Food Chem Toxicol 63:195–204
  • Frozza CO, Garcia CS, Gambato G, de Souza MD, Salvador M, Moura S, Padilha FF, et al. 2013. Chemical characterization, antioxidant and cytotoxic activities of Brazilian red propolis. Food Chem Toxicol 52:137–142
  • Fuchs D, Piller R, Linseisen J, Daniel H, Wenzel U. 2007. The human peripheral blood mononuclear cell proteome responds to a dietary flaxseed-intervention and proteins identified suggest a protective effect in atherosclerosis. Proteomics 7:3278–3288
  • Garcia-Bailo B, Toguri C, Eny KM, El-Sohemy A. 2009. Genetic variation in taste and its influence on food selection. OMICS 13:69–80
  • García-Cañas V, Simó C, Herrero M, Ibáñez E, Cifuentes A. 2012. Present and future challenges in food analysis: foodomics. Anal Chem 84:10150–10159
  • Gatto L, Vizcaino JA, Hermjakob H, Huber W, Lilley KS. 2010. Organelle proteomics experimental designs and analysis. Proteomics 10:3957–3969
  • Geiger T, Wehner A, Schaab C, Cox J, Mann M. 2012. Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Mol Cell Proteomics 11: M111.014050
  • Gomez-Cabrero D, Abugessaisa I, Maier D, Teschendorff A, Merkenschlager M, Gisel A, Ballestar E, et al. 2014. Data integration in the era of omics: current and future challenges. BMC Syst Biol 8:I1
  • Gorg A, Drews O, Luck C, Weiland F, Weiss W. 2009. 2-DE with IPGs. Electrophoresis 30:122–132
  • Grada A, Weinbrecht K. 2013. Next-generation sequencing: methodology and application. J Invest Dermatol 133:e11
  • Gupta S, Venkatesh A, Ray S, Srivastava S. 2014. Challenges and prospects for biomarker research: a current perspective from the developing world. Biochim Biophys Acta 1844:899–908
  • Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17:994–999
  • Hellstrom I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, et al. 2003. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res 63:3695–3700
  • Herrero M, Simó C, García-Cañas V, Ibáñez E, Cifuentes A. 2012. Foodomics: MS-based strategies in modern food science and nutrition. Mass Spectrom Rev 31:49–69
  • Høgdall E, Fung ET, Christensen IJ, Yip C, Nedergaard L, Engelholm SA, Risum S, et al. 2010. Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients. Proteomics Clin Appl 4:940–952
  • Jacob RE. 1994. Vitamin C. In: Shils ME, Olson JA, Shike M, editors. Modern nutrition in health and disease. Philadelphia: Lea & Febiger. p 432–448
  • Jang H, Serra C. 2014. Nutrition, epigenetics, and diseases. Clin Nutr Res 3:1–8
  • Jenab M, Salvini S, van Gils CH, Brustad M, Shakya-Shrestha S, Buijsse B, Verhagen H, et al. 2009. Dietary intakes of retinol, beta-carotene, vitamin D and vitamin E in the European Prospective Investigation into Cancer and Nutrition cohort. Eur J Clin Nutr 63:S150–S178
  • Kaaks R, Riboli E, Sinha R. 1997. Biochemical markers of dietary intake. IARC Sci Publ 142:103–126
  • Kellner R. 2000. Proteomics. Concepts and perspectives. Fresenius J Anal Chem 366:517–524
  • Kheterpal I, Scherp P, Kelley L, Wang Z, Johnson W, Ribnicky D, Cefalu WT. 2014. Bioactives from Artemisia dracunculus L. enhance insulin sensitivity via modulation of skeletal muscle protein phosphorylation. Nutrition 30:S43–S51
  • Kinross J, Li JV, Muirhead LJ, Nicholson J. 2014. Nutritional modulation of the metabonome: applications of metabolic phenotyping in translational nutritional research. Curr Opin Gastroenterol 30:196–207
  • Kussmann M, Panchaud A, Affolter M. 2010. Proteomics in nutrition: status quo and outlook for biomarkers and bioactives. J Proteome Res 9:4876–4887
  • Lescuyer P, Hochstrasser D, Rabilloud T. 2007. How shall we use the proteomics toolbox for biomarker discovery? J Proteome Res 6:3371–3376
  • Livingstone MB, Black AE. 2003. Markers of the validity of reported energy intake. J Nutr 133:895S–920S
  • Loria-Kohen V, Espinosa-Salinas I, Ramirez de Molina A, Casas-Agustench P, Herranz J, Molina S, Fonolla J, et al. 2014. A genetic variant of PPARA modulates cardiovascular risk biomarkers after milk consumption. Nutrition 30:1144–1150
  • Lueking A, Horn M, Eickhoff H, Bussow K, Lehrach H, Walter G. 1999. Protein microarrays for gene expression and antibody screening. Anal Biochem 270:103–111
  • Llorach R, Urpi-Sarda M, Tulipani S, Garcia-Aloy M, Monagas M, Andres-Lacueva C. 2013. Metabolomic fingerprint in patients at high risk of cardiovascular disease by cocoa intervention. Mol Nutr Food Res 57:962–973
  • Ma S, Chowdhury SK. 2013. Data acquisition and data mining techniques for metabolite identification using LC coupled to high-resolution MS. Bioanalysis 5:1285–1297
  • MacBeath G, Schreiber SL. 2000. Printing proteins as microarrays for high-throughput function determination. Science 289:1760–1763
  • Maciel-Dominguez A, Swan D, Ford D, Hesketh J. 2013. Selenium alters miRNA profile in an intestinal cell line: evidence that miR-185 regulates expression of GPX2 and SEPSH2. Mol Nutr Food Res 57:2195–2205
  • Mai A, Massa S, Rotili D, Cerbara I, Valente S, Pezzi R, Simeoni S, Ragno R. 2005. Histone deacetylation in epigenetics: an attractive target for anticancer therapy. Med Res Rev 25:261–309
  • Metzker ML. 2010. Sequencing technologies – the next generation. Nat Rev Genet 11:31–46
  • Milagro FI, Campion J, Cordero P, Goyenechea E, Gomez-Uriz AM, Abete I, Zulet MA, Martínez JA. 2011. A dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to diet-induced weight loss. FASEB J 25:1378–1389
  • Miller I, Crawford J, Gianazza E. 2006. Protein stains for proteomic applications: which, when, why? Proteomics 6:5385–5408
  • Minden JS. 2012. DIGE: past and future. Methods Mol Biol 854:3–8
  • Nygaard V, Hovig E. 2009. Methods for quantitation of gene expression. Front Biosci 14:552–569
  • O'Grada CM, Morine MJ, Morris C, Ryan M, Dillon ET, Walsh M, Gibney ER, et al. 2014. PBMCs reflect the immune component of the WAT transcriptome – implications as biomarkers of metabolic health in the postprandial state. Mol Nutr Food Res 58:808–820
  • Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M, et al. 2002. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1:376–386
  • Ordovas Munoz JM. 2013. Predictors of obesity: the “power” of the omics. Nutr Hosp 28:63–71
  • O'Sullivan A, Gibney MJ, Brennan L. 2011. Dietary intake patterns are reflected in metabolomic profiles: potential role in dietary assessment studies. Am J Clin Nutr 93:314–321
  • Page GP, Edwards JW, Barnes S, Weindruch R, Allison DB. 2003. A design and statistical perspective on microarray gene expression studies in nutrition: the need for playful creativity and scientific hard-mindedness. Nutrition 19:997–1000
  • Picotti P, Aebersold R, Domon B. 2007. The implications of proteolytic background for shotgun proteomics. Mol Cell Proteomics 6:1589–1598
  • Picotti P, Aebersold R. 2012. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 9:555–566
  • Potischman N. 2003. Biologic and methodologic issues for nutritional biomarkers. J Nutr 133:875S–880S
  • Potter JD. 2003. Epidemiology, cancer genetics and microarrays: making correct inferences, using appropriate designs. Trends Genet 19:690–695
  • Puiggros F, Sola R, Blade C, Salvado MJ, Arola L. 2011. Nutritional biomarkers and foodomic methodologies for qualitative and quantitative analysis of bioactive ingredients in dietary intervention studies. J Chromatogr A 1218:7399–7414
  • Qian WJ, Jacobs JM, Liu T, Camp DG 2nd, Smith RD. 2006. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics 5:1727–1744
  • Raiten DJ, Namaste S, Brabin B, Combs G Jr, L'Abbe MR, Wasantwisut E, Darnton-Hill I. 2011. Executive summary – biomarkers of nutrition for development: building a consensus. Am J Clin Nutr 94:633S–650S
  • Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, et al. 2013. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341:1241214
  • Rifai N, Gillette MA, Carr SA. 2006. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971–983
  • Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, et al. 2004. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3:1154–1169
  • Ross SA. 2010. Evidence for the relationship between diet and cancer. Exp Oncol 32:137–142
  • Ryan KK, Seeley RJ. 2013. Physiology. Food as a hormone. Science 339:918–919
  • Sanchez J, Bonet ML, Keijer J, van Schothorst EM, Molller I, Chetrit C, Martinez-Puig D, Palou A. 2014. Blood cells transcriptomics as source of potential biomarkers of articular health improvement: effects of oral intake of a rooster combs extract rich in hyaluronic acid. Genes Nutr 9:417–429
  • Scarano MI, Strazzullo M, Matarazzo MR, D'Esposito M. 2005. DNA methylation 40 years later: its role in human health and disease. J Cell Physiol 204:21–35
  • Schnolzer M, Jedrzejewski P, Lehmann WD. 1996. Protease-catalyzed incorporation of 18O into peptide fragments and its application for protein sequencing by electrospray and matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis 17:945–953
  • Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Månér S, et al. 2004. Large-scale copy number polymorphism in the human genome. Science 305:525–528
  • Shahzad K, Bionaz M, Trevisi E, Bertoni G, Rodriguez-Zas SL, Loor JJ. 2014. Integrative analyses of hepatic differentially expressed genes and blood biomarkers during the peripartal period between dairy cows overfed or restricted-fed energy prepartum. PLoS One 9:e99757
  • Sorby LA, Andersen SN, Bukholm IR, Jacobsen MB. 2010. Evaluation of suitable reference genes for normalization of real-time reverse transcription PCR analysis in colon cancer. J Exp Clin Cancer Res 29:144–153
  • Steinberg TH. 2009. Protein gel staining methods: an introduction and overview. Methods Enzymol 463:541–563
  • Swann JR, Claus SP. 2014. Nutrimetabonomics: nutritional applications of metabolic profiling. Sci Prog 97:41–47
  • Ulven SM, Myhrstad MC, Holven KB. 2014. Marine n−3 fatty acids and gene expression in peripheral blood mononuclear cells. Curr Cardiovasc Risk Rep 8:412–422
  • Van Dorsten FA, Daykin CA, Mulder TP, Van Duynhoven JP. 2006. Metabonomics approach to determine metabolic differences between green tea and black tea consumption. J Agric Food Chem 54:6929–6938
  • Vuckovic D, Dagley LF, Purcell AW, Emili A. 2013. Membrane proteomics by high performance liquid chromatography–tandem mass spectrometry: analytical approaches and challenges. Proteomics 13:404–423
  • Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, et al. 2011. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472:57–63
  • Washburn MP, Wolters D, Yates JR 3rd. 2001. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19:242–247
  • Wieczorek SJ, Tsongalis GJ. 2001. Pharmacogenomics: will it change the field of medicine? Clin Chim Acta 308:1–8
  • Wishart DS. 2011. Advances in metabolite identification. Bioanalysis 3:1769–1782
  • Wolters DA, Washburn MP, Yates JR 3rd. 2001. An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 73:5683–5690
  • World Health Organization. 2002. The world health report 2002: reducing risks, promoting healthy life. Available at: http://www.who.int/whr/2002/en/. Accessed on 13 April 2015.
  • World Health Organization. 2003. Technical report series: diet, nutrition and the prevention of chronic diseases, vol. 916, pp 1–149. Available at: http://whqlibdoc.who.int/trs/who_trs_916.pdf. Accessed on 13 April 2015.
  • Zhang AH, Sun H, Qiu S, Wang XJ. 2013. NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis. Magn Reson Chem 51:549–556

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.